Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ostacher

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
The American Journal of Psychiatry|September 1, 2022
Treatments for Depression in Bipolar II Disorder: Reply to Durgam et alMichael Ostacher
CNS Spectrums|May 3, 2017
Mixed features in major depressive disorder: diagnoses and treatmentsTrisha Suppes, Michael Ostacher
Psychiatry Research|February 14, 2026
Trustworthiness issues in Yari-Renani and Zari's (2025) study "Advancing depression treatment: a multi-center randomized controlled trial of dynamic interpersonal therapy versus CBT and pharmacotherapy on symptoms, sleep, and cognition"Martin Plöderl, Ian Hussey, Michael Ostacher
Evidence-Based Mental Health|January 22, 2020
Using big data to advance mental health researchAnne Duffy, Maria Faurholt-Jepsen, Michael Ostacher
CNS Spectrums|July 4, 2006
Aripiprazole-related tardive dyskinesiaGuy Maytal, Michael Ostacher, Theodore A Stern
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 15, 2019
How genome-wide association studies (GWAS) made traditional candidate gene studies obsoleteLaramie E Duncan, Michael Ostacher, Jacob Ballon
The Journal of Clinical Psychiatry|July 7, 2017
Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Major Depressive DisorderRoger S McIntyre, Trisha Suppes, Rajiv Tandon, et al.
Pharmacopsychiatry|July 6, 2018
A Novel Study Design to Systematically Explore the Impact of Trial Methodology on Psychopharmacological Treatment Outcome in Patients with DepressionEmanuel Severus, Cathrin Sauer, Michael Bauer, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 8, 2017
Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysisMichael Ostacher, Daisy Ng-Mak, Pankaj Patel, et al.
Biological Psychiatry|February 5, 2008
Euthymic patients with bipolar disorder show decreased reward learning in a probabilistic reward taskDiego A Pizzagalli, Elena Goetz, Michael Ostacher, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
The American Journal of Psychiatry|September 1, 2022
Treatments for Depression in Bipolar II Disorder: Reply to Durgam et alMichael Ostacher
CNS Spectrums|May 3, 2017
Mixed features in major depressive disorder: diagnoses and treatmentsTrisha Suppes, Michael Ostacher
Psychiatry Research|February 14, 2026
Trustworthiness issues in Yari-Renani and Zari's (2025) study "Advancing depression treatment: a multi-center randomized controlled trial of dynamic interpersonal therapy versus CBT and pharmacotherapy on symptoms, sleep, and cognition"Martin Plöderl, Ian Hussey, Michael Ostacher
Evidence-Based Mental Health|January 22, 2020
Using big data to advance mental health researchAnne Duffy, Maria Faurholt-Jepsen, Michael Ostacher
CNS Spectrums|July 4, 2006
Aripiprazole-related tardive dyskinesiaGuy Maytal, Michael Ostacher, Theodore A Stern
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 15, 2019
How genome-wide association studies (GWAS) made traditional candidate gene studies obsoleteLaramie E Duncan, Michael Ostacher, Jacob Ballon
The Journal of Clinical Psychiatry|July 7, 2017
Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Major Depressive DisorderRoger S McIntyre, Trisha Suppes, Rajiv Tandon, et al.
Pharmacopsychiatry|July 6, 2018
A Novel Study Design to Systematically Explore the Impact of Trial Methodology on Psychopharmacological Treatment Outcome in Patients with DepressionEmanuel Severus, Cathrin Sauer, Michael Bauer, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 8, 2017
Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysisMichael Ostacher, Daisy Ng-Mak, Pankaj Patel, et al.
Biological Psychiatry|February 5, 2008
Euthymic patients with bipolar disorder show decreased reward learning in a probabilistic reward taskDiego A Pizzagalli, Elena Goetz, Michael Ostacher, et al.
Pageof 3